Orcein is a natural dye that has been used for centuries to color textiles, leather, and food. It is derived from lichens, which are symbiotic organisms composed of a fungus and an alga or a cyanobacterium. Orcein has also been found to have biological activity, making it a subject of interest in medical, environmental, and industrial research.
Orcein can be synthesized or extracted from lichens using various methods. The most commonly used methods are acid extraction, alkaline extraction, and enzymatic extraction. Acid extraction involves boiling the lichen in an acidic solution, such as hydrochloric acid or sulfuric acid, to release the orcein. Alkaline extraction involves boiling the lichen in an alkaline solution, such as ammonia or sodium hydroxide, to release the orcein. Enzymatic extraction involves using enzymes, such as cellulase or pectinase, to break down the lichen and release the orcein. Each method has its own efficiency and yield, with acid extraction being the most efficient and yielding the highest amount of orcein. However, acid extraction is also the most environmentally and safety hazardous method, as it involves the use of strong acids. Alkaline extraction and enzymatic extraction are more environmentally and safety friendly, but they yield lower amounts of orcein.
Chemical Structure and Biological Activity
Orcein is a complex molecule composed of several components, including orcinol, lecanoric acid, and erythrin. Its chemical structure has been elucidated using various spectroscopic techniques, such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). Orcein has been found to have biological activity, particularly as an antioxidant and an antimicrobial agent. Its mechanism of action involves scavenging free radicals and inhibiting the growth of microorganisms. Orcein has also been found to have potential as an anticancer agent, as it can induce apoptosis in cancer cells.
Biological Effects
Orcein has been found to have various effects on cell function and signal transduction. It can modulate the expression of genes involved in inflammation, oxidative stress, and apoptosis. Orcein can also activate various signaling pathways, such as the mitogen-activated protein kinase (MAPK) pathway and the nuclear factor-kappa B (NF-κB) pathway. Its potential therapeutic effects include the treatment of cancer, inflammation, and microbial infections. However, orcein can also have toxic effects, particularly at high doses. It can induce DNA damage and cell death, and it can also cause liver and kidney damage.
Applications
Orcein has various applications in medical, environmental, and industrial research. In medical research, orcein has been studied for its potential role in drug development. It has been found to have anticancer, anti-inflammatory, and antimicrobial properties, making it a promising candidate for the development of new drugs. Clinical trials have also been conducted to evaluate the safety and efficacy of orcein-based therapies. In environmental research, orcein has been studied for its effects on ecosystems and its role in pollution management. It has been found to have potential as a natural dye for textiles and as a bioindicator of environmental pollution. In industrial research, orcein has been used in manufacturing processes to improve product quality and efficiency. Health and safety considerations are important in the use of orcein in industrial applications, as it can be toxic at high doses.
Future Perspectives and Challenges
The use and study of orcein face several limitations and challenges. One of the main challenges is the limited availability of lichens, which are the source of orcein. The extraction of orcein from lichens is also a time-consuming and labor-intensive process. Another challenge is the toxicity of orcein at high doses, which limits its use in medical and industrial applications. Possible solutions and improvements include the development of more efficient and environmentally friendly methods of extraction, the synthesis of orcein analogs with improved bioactivity and safety profiles, and the identification of new sources of orcein. Future trends and prospects in the application of orcein in scientific research include the development of new drugs and therapies, the use of orcein as a natural dye and bioindicator, and the exploration of its potential in other fields, such as agriculture and food science. Conclusion Orcein is a natural dye with biological activity that has been studied for its potential therapeutic, environmental, and industrial applications. Its synthesis or extraction involves various methods, each with its own efficiency and yield, and environmental and safety considerations. Orcein's chemical structure and biological activity have been elucidated, and its effects on cell function and signal transduction have been studied. Orcein has potential therapeutic and toxic effects, and its applications in medical, environmental, and industrial research have been explored. The use and study of orcein face several limitations and challenges, but possible solutions and improvements are being pursued. Orcein's future prospects in scientific research are promising, and its potential in various fields is being explored.
Product FAQ
Q1: How Can I Obtain a Quote for a Product I'm Interested In?
To receive a quotation, send us an inquiry about the desired product.
The quote will cover pack size options, pricing, and availability details.
If applicable, estimated lead times for custom synthesis or sourcing will be provided.
Quotations are valid for 30 days, unless specified otherwise.
Q2: What Are the Payment Terms for Ordering Products?
New customers generally require full prepayment.
NET 30 payment terms can be arranged for customers with established credit.
Contact our customer service to set up a credit account for NET 30 terms.
We accept purchase orders (POs) from universities, research institutions, and government agencies.
Q3: Which Payment Methods Are Accepted?
Preferred methods include bank transfers (ACH/wire) and credit cards.
Request a proforma invoice for bank transfer details.
For credit card payments, ask sales representatives for a secure payment link.
Checks aren't accepted as prepayment, but they can be used for post-payment on NET 30 orders.
Q4: How Do I Place and Confirm an Order?
Orders are confirmed upon receiving official order requests.
Provide full prepayment or submit purchase orders for credit account customers.
Send purchase orders to sales@thebiotek.com.
A confirmation email with estimated shipping date follows processing.
Q5: What's the Shipping and Delivery Process Like?
Our standard shipping partner is FedEx (Standard Overnight, 2Day, FedEx International Priority), unless otherwise agreed.
You can use your FedEx account; specify this on the purchase order or inform customer service.
Customers are responsible for customs duties and taxes on international shipments.
Q6: How Can I Get Assistance During the Ordering Process?
Reach out to our customer service representatives at sales@thebiotek.com.
For ongoing order updates or questions, continue using the same email.
Remember, we're here to help! Feel free to contact us for any queries or further assistance.
Quick Inquiry
Note: Kindly utilize formal channels such as professional, corporate, academic emails, etc., for inquiries. The use of personal email for inquiries is not advised.
Novel Long-Acting Prostacyclin Agonist, Promoting Synthesis of Hepatocyte Growth Factor and Increasing Cyclic AMP Concentration via IP-Receptor Signaling Ono 1301 is a non-prostanoid prostaglandin I2 mimetic coumpound with inhibitory activity against thromboxane A2 synthase. It is also a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA. ONO-1301 suppresses pancreatic fibrosis in the DBTC-induced CP model by inhibiting monocyte activity not only with induction of HGF but also by ONO-1301 itself. It also works through promoting synthesis of hepatocyte growth factor and increasing cyclic AMP concentration via IP-receptor signaling.
ONO-2952 is under investigation in clinical trial NCT01887002 (Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)).
Ono 3403 is a synthetic serine protease inhibitor hat inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock. Oral administration of the potent serine protease inhibitor ONO-3403 has an antitumor effect on malignant tumors suggested by the growth inhibition of mouse skin tumors in research.
Ono-3708 is a potent antagonist of the thromboxane A2/prostaglandin endoperoxide receptor in vitro and in vivo and may be of therapeutic use in preventing cerebral vasospasm. Recent studies suggest that Ono-378 could play an important role in the pathogenesis of thrombosis and that ONO-3708 may have therapeutic advantages in preventing thrombosis.
Ono-3307 is a protease inhibitor potentially for the treatment of thrombosis. ONO-3307 competitively inhibited trypsin, thrombin, plasma kallikrein, plasmin, pancreatic kallikrein and chymotrypsin; and their Ki values were 0.048 microM, 0.18 microM, 0.29 microM, 0.31 microM, 3.6 microM and 47 microM, respectively. In addition, ONO-3307 inhibited both elastase release from N-formyl-Met-Leu-Phe (fMLP)-stimulated leukocytes and tissue thromboplastin release from endotoxin-stimulated leukocytes. ONO-3307 exhibits a wide range of inhibitory effects on various proteases, and ONO-3307 may be useful for the treatment of protease-mediated diseases such as thrombosis and DIC.
ONO-4578, also known as BMS 986310, is an orally bioavailable antagonist of the prostaglandin E2 receptor subtype 4 (PTGER4; EP4), with potential analgesic, immunomodulating and antineoplastic activities. Upon administration, the EP4 antagonist ONO-4578 selectively targets and binds to EP4, inhibiting the binding of the immunosuppressive prostaglandin E2 (PGE2) to EP4. This prevents the activation of EP4 and inhibits PGE2-EP4-mediated signaling, thereby inhibiting proliferation of tumor cells in which the PGE2-EP4 signaling pathway is over-activated.